glp 1 prospect Trends in the Development of GLP-1 Receptor Agonists Glucagon-like peptide 1 (GLP-1) -

Rye P, Modi R, Cawsey S, et al

conceived of the project, W.Z

Here, I review this remarkable development from the earliest observations of glucose lowering and modest weight losses with native glucagon-like peptide (GLP)-1 and short acting compounds, to the recent development of highly active formulations and new molecules

Seek support Referring patients to professional counseling or therapy, as well as support groups for weight management, can provide invaluable assistance in navigating the challenges of discontinuing weight loss medications

[DOI] [PMC free article] [PubMed] [Google Scholar] 71.Capozzi ME, DiMarchi RD, Tschp MH, Finan B, and Campbell JE, Targeting the Incretin/Glucagon System With Triagonists to Treat Diabetes, Endocrine Reviews 39, no